research Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model
Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Kuala Lumpur, Malaysia

Henrico, VA, United States

Singapore, Singapore

Ostrava, Czechia
Atlanta, GA, United States

Chelmsford, United Kingdom